Octreotide for nausea and vomiting after chemotherapy and stem-cell transplantation. | Lancet;353(9155): 846, 1999 Mar 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Octreotide for nausea and vomiting after chemotherapy and stem-cell transplantation.

Nordesjö-Haglund, G; Lönnqvist, B; Lindberg, G; Hellström-Lindberg, E.

Lancet ; 353(9155): 846, 1999 Mar 06.

Article in En | MEDLINE | ID: mdl-10459993

Subject(s)

Antineoplastic Agents/adverse effects; Hematopoietic Stem Cell Transplantation/adverse effects; Nausea/drug therapy; Octreotide/therapeutic use; Vomiting/drug therapy; Adult; Humans; Middle Aged; Nausea/etiology; Pilot Projects; Vomiting/etiology

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Octreotide / Hematopoietic Stem Cell Transplantation / Nausea / Antineoplastic Agents Type of study: Etiology_studies Limits: Adult / Humans / Middle aged Language: En Journal: Lancet Year: 1999 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Octreotide / Hematopoietic Stem Cell Transplantation / Nausea / Antineoplastic Agents Type of study: Etiology_studies Limits: Adult / Humans / Middle aged Language: En Journal: Lancet Year: 1999 Document type: Article